Drexel University Co-op program at Bristol Myers Squibb
Posted on: 30 Jan 2021
Princeton, NJ
Job Description
At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Drexel Program Dates: March 29, 2021 September 17, 2021
The co-op will be an active BMS IT team member and make key contributions. The candidate will be expected to be a fast learner in a dynamic environment.
Requirements: Candidates must be currently enrolled in a Drexel University program in a Bachelors, Masters, or MBA degree.
Desired background/degrees include:
Computer Science, Software Engineering, Computer Engineering, Information Systems, Mathematics, Business Analytics, Business Administration, Business & Engineering, Operations Management, Management Information Systems, Organizational Management, Technology Innovation Management, Computing & Security Technology, Data Science, Engineering Technology, Information Technology
Locations: Central New Jersey
How to Apply: Applications are currently being accepted and will adhere to the Drexel Co-op Calendar schedule for Spring/Summer 2020-2021. Please enter the Steinbright Drexel recruiting system to see open positions and full job posting details. Students must apply through the Steinbright system and the BMS Workday system to qualify.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Celgene
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
-
IndustryBiopharmaceuticals
-
No. of Employees8, 852
-
Website
-
Jobs Posted1399
